Y-MABS THERAPEUTICS INC

CUSIP: 984241109 Class: Common Stock

RHUMBLINE ADVISERS's Holding History (CIK: 0001115418)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 68,399 Value ($000) $308 Avg Close Range
Q1 2025
Shares 53,909 Value ($000) $239 Avg Close Range
Q4 2024
Shares 51,452 Value ($000) $403 Avg Close Range
Q3 2024
Shares 52,315 Value ($000) $688 Avg Close Range
Q2 2024
Shares 54,368 Value ($000) $657 Avg Close Range
Q1 2024
Shares 55,224 Value ($000) $898 Avg Close Range
Q4 2023
Shares 54,013 Value ($000) $368 Avg Close Range
Q3 2023
Shares 54,887 Value ($000) $299 Avg Close Range
Q2 2023
Shares 52,789 Value ($000) $358 Avg Close Range
Q1 2023
Shares 48,634 Value ($000) $0 Avg Close Range
Q4 2022
Shares 48,749 Value ($000) $0 Avg Close Range
Q3 2022
Shares 46,805 Value ($000) $675 Avg Close Range
Q2 2022
Shares 43,511 Value ($000) $658 Avg Close Range
Q1 2022
Shares 36,092 Value ($000) $429 Avg Close Range
Q4 2021
Shares 36,417 Value ($000) $590 Avg Close Range
Q3 2021
Shares 37,022 Value ($000) $1,057 Avg Close Range
Q2 2021
Shares 35,021 Value ($000) $1,184 Avg Close Range
Q1 2021
Shares 35,696 Value ($000) $1,079 Avg Close Range
Q4 2020
Shares 38,496 Value ($000) $1,906 Avg Close Range
Q3 2020
Shares 36,555 Value ($000) $1,403 Avg Close Range
Q2 2020
Shares 41,875 Value ($000) $1,809 Avg Close Range
Q1 2020
Shares 28,048 Value ($000) $732 Avg Close Range
Q4 2019
Shares 27,222 Value ($000) $851 Avg Close Range
Q3 2019
Shares 22,053 Value ($000) $575 Avg Close Range
Q2 2019
Shares 21,437 Value ($000) $490 Avg Close Range